|Articles|May 31, 2017
TD2 and Deep 6 AI Announce Partnership
Translational Drug Development (TD2) and Deep 6 AI have agreed to collaborate in the fields of oncology and fibrosis.
Advertisement
Translational Drug Development (TD2) and Deep 6 AI have agreed to collaborate in the fields of oncology and fibrosis to match eligible patients with the appropriate clinical trials.
Read the full release
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Breaking the Efficacy Ceiling in IBD and Beyond
2
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
3
ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5